Mulvihill Mark J, Kan Julie L C, Beck Patricia, Bittner Mark, Cesario Cara, Cooke Andrew, Keane David M, Nigro Anthony I, Nillson Christy, Smith Vanessa, Srebernak Mary, Sun Feng-Lei, Vrkljan Michael, Winski Shannon L, Castelhano Arlindo L, Emerson David, Gibson Neil
OSI Pharmaceuticals, Inc., 1 Bioscience Park Drive, Farmingdale, NY 11735, USA.
Bioorg Med Chem Lett. 2005 Mar 15;15(6):1669-73. doi: 10.1016/j.bmcl.2005.01.044.
A series of [2-imidazol-1-yl-2-(6-alkoxy-naphthalen-2-yl)-1-methyl-ethyl]-dimethyl-amines were designed and synthesized as CYP26 inhibitors, serving as retinoic acid metabolic blocking agents (RAMBA's).
设计并合成了一系列[2-咪唑-1-基-2-(6-烷氧基萘-2-基)-1-甲基乙基]-二甲胺作为细胞色素P450 26(CYP26)抑制剂,用作维甲酸代谢阻断剂(RAMBA)。